Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Morphic Holding (MORF) is now available.
Morphic Holding, Inc. has launched an at-the-market offering program allowing for the sale of up to $350 million of its common stock through TD Securities (USA) LLC. This flexible financing strategy enables the company to sell shares at prevailing market prices, with TD Cowen receiving a commission of up to 3%. Morphic intends to use the proceeds for general corporate purposes, including research, clinical trials, and potential acquisitions. The move follows the company’s termination of a previous agreement with Jefferies LLC, under which it sold over $139 million in common stock.
See more insights into MORF stock on TipRanks’ Stock Analysis page.